Professional Summary

Professional Overview

Charlie Wagner is an experienced finance executive currently serving as the EVP & Chief Financial Officer at Vertex Pharmaceuticals, a leading global biotechnology company. With a strong background in financial management, strategic planning, and operational excellence, he brings deep expertise in the pharmaceutical and life sciences industries.

Current Role

As EVP & Chief Financial Officer at Vertex Pharmaceuticals, Charlie is responsible for overseeing the company's financial operations, including financial planning and analysis, treasury, tax, and investor relations. He plays a critical role in driving the company's growth and profitability, managing its financial resources, and supporting strategic decision-making. Under his leadership, Vertex has achieved impressive financial results and maintained a strong balance sheet.

Career Progression

Prior to joining Vertex, Charlie served as the EVP Finance & Chief Financial Officer at Ortho Clinical Diagnostics, where he was instrumental in the company's successful transition to a publicly-traded entity. Before that, he held the role of EVP Finance & Administration, and Chief Financial Officer at Bruker Corporation, a leading provider of scientific instrumentation. Charlie's earlier career includes serving on the Board of Directors and Audit Committee Chairperson at Good Start Genetics, a pioneering genetic screening company.

Academic Background

Charlie holds a Bachelor's degree in Accounting from a prestigious university, where he graduated with honors. His strong academic foundation has provided a solid foundation for his successful finance career.

Areas of Expertise

Throughout his career, Charlie has developed a deep expertise in financial management, strategic planning, and operational optimization. He is adept at driving cost efficiencies, improving financial reporting, and overseeing complex financial transactions. Additionally, his experience in the pharmaceutical and life sciences industries has given him a strong understanding of the unique challenges and opportunities in these sectors.

Professional Impact

Charlie's leadership and financial acumen have had a significant impact on the organizations he has served. At Vertex Pharmaceuticals, he has played a pivotal role in securing the company's strong financial position and supporting its strategic growth initiatives. His contributions have been instrumental in Vertex's ability to invest in research and development, expand its portfolio of innovative treatments, and deliver value to shareholders.

Conclusion

With his extensive experience, proven track record of success, and strong financial expertise, Charlie Wagner is poised to continue driving Vertex Pharmaceuticals' growth and success in his role as EVP & Chief Financial Officer. His strategic vision, operational excellence, and commitment to creating shareholder value make him a valuable asset to the company and the broader pharmaceutical industry.